Search the web
Sign In
New User? Sign Up
AIDS_ASIA · AIDS Analysis Asia Pacific e_Newsletter
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Hear how Yahoo! Groups has changed the lives of others. Take me there.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
New Virulent Strain of HIV Virus (3-DCR HIV) reported   Message List  
Reply | Forward Message #260 of 1636 |

New York City: Gay man catches super HIV, no treatment works
Press Release

New York City Department of Health and Mental Hygiene Office of
Communications: FOR IMMEDIATE RELEASE. Friday, February 11, 2005
*****

NEW YORK CITY - February 11, 2005 - A highly resistant strain of rapidly
progressive human immunodeficiency virus (HIV) has been diagnosed for the
first time in a New York City resident who had not previously undergone
antiviral drug treatment, according to the Department of Health and Mental
Hygiene (DOHMH). The strain of three-class antiretroviral-resistant HIV - or
3-DCR HIV - does not respond to three classes of anti-retroviral medication,
and also appears to greatly shorten the interval between HIV infection and
the onset of AIDS.

The patient is a male in his mid-40s who reported multiple male sex partners
and unprotected anal intercourse, often while using crystal methamphetamine
(crystal meth). He was first diagnosed with HIV in December 2004 and appears
to have been recently infected. The diagnosis of 3-DCR HIV was made shortly
thereafter at the Aaron Diamond AIDS Research Center. Since then, the
patient has developed AIDS. DOHMH is counseling and offering HIV testing to
those contacts of the patient who have been identified.

While drug resistance is increasingly common among patients who have been
treated for HIV, cases of 3-DCR HIV in newly-diagnosed, previously untreated
patients are extremely rare, and the combination of this pattern of drug
resistance and rapid progression to AIDS may not have been seen previously.
Strains of 3-DCR HIV are resistant to three of the four available types of
antiviral drugs that are most commonly prescribed:
nucleoside reverse transcriptase inhibitors, non-nucleoside reverse
transcriptase inhibitors, and protease inhibitors. This strain also caused a
rapid onset of AIDS, which usually occurs more than ten years after initial
infection with HIV. In this patient's case, onset of AIDS appears to have
occurred within two to three months, and at most 20 months, after HIV
infection.

Health Commissioner Thomas R. Frieden, MD, MPH said, "This case is a wake-up
call. First, it's a wake up call to men who have sex with men, particularly
those who may use crystal methamphetamine. Not only are we seeing syphilis
and a rare sexually transmitted disease - lymphogranuloma venereum - among
these men, now we've identified this strain of HIV that is difficult or
impossible to treat and which appears to progress rapidly to AIDS. This
community successfully reduced its risk of HIV in the 1980s, and it must do
so again to stop the devastation of HIV/AIDS and the spread of
drug-resistant strains. Second, doctors in New York City must increase HIV
prevention counseling, increase HIV testing, obtain drug susceptibility
testing for patients testing HIV-positive who have not yet been treated,
improve adherence to antiretroviral treatment, and improve notification of
partners of HIV-infected patients. Third, the public health community has to
improve our monitoring of both HIV treatment and of HIV drug resistance, and
we have to implement prevention strategies that work."

The Health Department recently issued a Health Alert to physicians,
hospitals and other medical providers asking them to test all previously
untreated patients newly diagnosed cases for anti-HIV drug susceptibility.

The Department is monitoring laboratories for additional cases of 3-DCR HIV
in newly diagnosed persons. DOHMH is also working with New York State to
establish a long-term system for monitoring drug resistance in HIV-positive
patients who have not yet undergone treatment.

Dr. Frieden added, "Patients who are on treatment for HIV/AIDS and are doing
well do not need susceptibility testing unless advised to by their
physician."

REMARKS BY MEDICAL AND COMMUNITY LEADERS
Dr. David Ho, CEO and Director of the Aaron Diamond AIDS Research Center,
said "This patient's infection with an HIV-1 strain that is not amenable to
standard antiretroviral therapy, along with his rapid clinical and
immunological deterioration, is alarming. While this remains a single case,
it is prudent to closely watch for any additional possible cases while
continuing to emphasize the importance of reducing HIV risk behavior."

"The rapidly growing crystal meth epidemic in New York city continues to
play a significant role in facilitating the transmission of HIV. In light of
the emergence of this virulent new strain, health care providers must be
especially vigilant in not only recognizing and diagnosing HIV infection,
but also in recognizing the signs and symptoms of crystal methamphetamine
use in their patients," said Dr. Antonio Urbina, Medical Director of HIV
education and training, at St. Vincent's Catholic Medical Center.

"Callen-Lorde is deeply concerned about this newly identified case of
multiple drug resistant HIV," said Jay Laudato, Executive Director of the
Callen-Lorde Community Health Center. "We urge all persons, both HIV
negative and positive, to only engage in safer sex practices in order to
prevent new infections or re-infection. For those persons who don't know
their status, we urge HIV testing and obtaining the information and support
necessary to reduce their risk for HIV infection. We also ask all gay and
bisexual men to become knowledgeable about the dangers of crystal
methamphetamine and in particular its relationship to sexual risk taking."

Dr. James Braun, President of the Physicians Research Network, said "We
believe that the transmission of treatment-resistant HIV was a disaster
waiting to happen, particularly in communities where safer sex is not
practiced regularly and in light of people using drugs like crystal meth.
All primary care providers in acute care settings need to know how to
diagnose HIV in its earliest stages and where to refer people so that new
infections are properly worked up and treated."

"HIV prevention is an ongoing process," said Ana Oliveira, Executive
Director of Gay Men's Health Crisis. We have to double our efforts and
resources to maintain treatment and prevention education for people who are
infected as well as for those who are not. New Yorkers must be vigilant and
know that infection with resistant strains of HIV can be avoided. People
living with HIV can live healthy and satisfying lives by protecting
themselves and their partners, regardless of HIV status."

Tokes M. Osubu, Executive Director of Gay Men of African Descent, said,
"This is the news we have all been fearing. While the recent advances in HIV
treatment have led to the improvement of countless lives, we have always
known that many people respond poorly to these therapies and for many
others, the side effects are devastating. Continued education about staying
safe and avoiding HIV remains our most potent weapon."

Dr. Jay Dobkin, Director of the AIDS Program at Columbia University Medical
Center, said, "This case is a striking reminder that the risk of getting
infected with HIV has not gone away. In fact, risky behavior may be even
more dangerous now since there is a chance of infection with a virus we may
not be able to treat."

"This case should drive home the point that substance use can lead to unsafe
sex, and unsafe sex can lead to infection with a highly drug-resistant
strain of HIV that can be extraordinarily difficult to treat and may cause
rapid progression to AIDS," said Roy M. Gulick, MD, Associate Professor of
Medicine at Weill Cornell Medical College in Manhattan.

Dr. Jack DeHovitz, Professor at SUNY-Downstate Medical Center said, "This
finding supports the need for enhanced availability of HIV testing, as well
as preventive interventions, which are effective in reducing subsequent HIV
transmission."

Know Your HIV Status There is an epidemic of HIV and AIDS in New York
City: more than 88,000 New Yorkers are known to be living with HIV/AIDS, and
an estimated 20,000 more are believed to be living with HIV/AIDS and don't
know it.

By knowing your HIV status, you can protect yourself, anyone you are having
sex with, and, if you are pregnant or planning pregnancy, your baby. Free
and fully confidential STD exams and treatment, as well as confidential or
anonymous HIV testing, are available at Health Department clinics throughout
New York City.

Health insurance, proof of citizenship and/or parental
consent are not required to receive these services. Please call 311 or visit
HYPERLINK "http://www.nyc.gov/health"http://www.nyc.gov/health for a list of
clinics and hours of operation.






Mon Feb 14, 2005 4:28 am

AIDS_ASIA@yahoogroups.com
Send Email Send Email

Forward
Message #260 of 1636 |
Expand Messages Author Sort by Date

New York City: Gay man catches super HIV, no treatment works Press Release New York City Department of Health and Mental Hygiene Office of Communications: FOR...
AIDS_ASIA
AIDS_ASIA@yahoogroups...
Send Email
Feb 14, 2005
10:26 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help